GlassScriptPhysician profile
Todd D Elmore
NPI 1104854439
$12,089.17
in general payments reported to CMS, 2019-2025
59 companies · $2,770 in 2025
The $2,770 reported for 2025 was more than what 78% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,595 · 2020: $828 · 2021: $906 · 2022: $689 · 2023: $1,948 · 2024: $3,354 · 2025: $2,770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,770 · Education: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,770.24 |
| Education | $301.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,163.08 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $849.15 | 2019-2025 | |
| Ucb, INC. | $749.92 | 2019-2025 | Nayzilam, Zilbrysq, Briviact |
| Alexion Pharmaceuticals, INC. | $710.68 | 2019-2025 | Ultomiris, Soliris |
| Lilly USA, LLC | $646.18 | 2019-2025 | Reyvow, Emgality, Kisunla |
| Neurocrine Biosciences, INC. | $594.07 | 2023-2025 | Ingrezza, Ongentys |
| Teva Pharmaceuticals USA, INC. | $549.96 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Biogen, INC. | $547.07 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Amgen INC. | $391.96 | 2019-2025 | Uplizna |
| Supernus Pharmaceuticals, INC. | $372.29 | 2019-2023 | |
| Mallinckrodt Hospital Products INC. | $323.44 | 2021-2025 | Acthar |
| Argenx US, INC. | $284.91 | 2023-2025 | Vyvgart, Vyvgart Hytrulo |
| Lundbeck LLC | $273.57 | 2021-2025 | Vyepti, Rexulti |
| Sk Life Science, INC. | $272.82 | 2020-2025 | |
| Celgene Corporation | $262.47 | 2021-2025 | Zeposia |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $256.25 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Pfizer INC. | $237.61 | 2019-2025 | |
| Emd Serono, INC. | $221.25 | 2019-2024 | Mavenclad |
| Eisai INC. | $208.64 | 2020-2025 | |
| Neurelis, INC. | $198.89 | 2020-2025 | Valtoco |
| Sumitomo Pharma America, INC. | $194.64 | 2023-2024 | Aptiom |
| Allergan, INC. | $175.93 | 2019-2021 | |
| Genentech USA, INC. | $172.63 | 2019-2024 | Ocrevus, Ocrevus Zunovo |
| Catalyst Pharmaceuticals, INC. | $155.15 | 2023-2025 | Firdapse |
| Tg Therapeutics, INC. | $152.42 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $139.61 | 2022-2024 | Xarelto |
| Genzyme Corporation | $130.42 | 2019-2025 | |
| Csl Behring | $130.31 | 2024-2025 | Hizentra |
| Merz Pharmaceuticals, LLC | $129.94 | 2024-2025 | Inbrija, Xeomin, Ampyra |
| Grifols USA, LLC | $119.60 | 2020-2025 | Gamunex-C |
| Amneal Pharmaceuticals LLC | $118.99 | 2024-2025 | Crexont, Rytary |
| Stryker Corporation | $116.13 | 2019-2021 | |
| Medtronic USA, INC. | $114.16 | 2019 | |
| Vanda Pharmaceuticals INC. | $109.14 | 2024 | Ponvory |
| Adamas Pharmaceuticals, INC. | $81.36 | 2020-2021 | |
| Depuy Synthes Sales INC. | $70.56 | 2020 | |
| Chiesi USA, INC. | $62.79 | 2021-2023 | Cleviprex |
| Acorda Therapeutics, INC | $62.60 | 2023 | Ampyra, Inbrija |
| Zimmer Biomet Holdings, INC. | $59.52 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $56.10 | 2021 | |
| Sunovion Pharmaceuticals INC. | $55.18 | 2022 | |
| Janssen Biotech, INC. | $49.64 | 2025 | Tremfya |
| Ge Healthcare | $48.52 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $46.25 | 2023 | Andexxa |
| Takeda Pharmaceuticals U.S.A., INC. | $44.78 | 2023-2024 | Hyqvia |
| Kedrion Biopharma, INC. | $42.80 | 2025 | Rhogam Ultra-Filtered Plus, Albuked, Koate |
| Portola Pharmaceuticals, LLC | $41.66 | 2019 | |
| Impel Pharmaceuticals INC. | $40.29 | 2023 | Trudhesa |
| Ani Pharmaceuticals, INC. | $38.31 | 2024-2025 | Purified Cortrophin Gel |
| Abbott Laboratories | $35.34 | 2022-2024 | Infinity |
| Acadia Pharmaceuticals INC | $29.43 | 2025 | Nuplazid |
| Tanabe Pharma America, INC. | $25.54 | 2025 | Radicava |
| Biohaven Pharmaceutical Holding Company LTD. | $24.46 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $22.02 | 2020 | |
| Boston Scientific Corporation | $17.54 | 2019 | |
| Springworks Therapeutics, INC. | $17.23 | 2025 | Gomekli |
| Medtronic Vascular, INC. | $14.99 | 2019 | |
| Ceribell, INC. | $14.84 | 2023 | Ceribell Rapid Response Eeg |
| Aprecia Pharmaceuticals, LLC | $14.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Elmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.